Interleukin‐17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental Spondyloarthritis-Reference-Cited by-同舟云学术

Interleukin‐17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental Spondyloarthritis

Published:2019-02-18 Issue:4 Volume:71 Page:612-625
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Tok Melissa N.¹,Duivenvoorde Leonie M.¹,Kramer Ina²,Ingold Peter²,Pfister Sabina²,Roth Lukas²,Blijdorp Iris C.¹,Sande Marleen G. H.¹,Taurog Joel D.³,Kolbinger Frank²,Baeten Dominique L.⁴

Affiliation:

1. Amsterdam UMCUniversity of Amsterdam Amsterdam The Netherlands

2. Novartis Institutes for BioMedical Research Basel Switzerland

3. University of Texas Southwestern Medical Center Dallas

4. Academic Medical Centre/University of AmsterdamAmsterdam, The Netherlands, and UCB Pharma Slough UK

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.40770

Reference47 articles.

1. Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography

2. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis

3. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept

4. Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors

5. Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-17 inhibitors in axial spondyloarthritis. An overview;Expert Opinion on Biological Therapy;2024-08-21

2. Some features of osteogenesis in ankylosing spondylitis and the possibilities of treatment with bisphosphonates;Modern Rheumatology Journal;2024-06-15

3. Identification and bioinformatics analysis of lncRNAs in serum of patients with ankylosing spondylitis;BMC Musculoskeletal Disorders;2024-04-15

4. Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation;Frontiers in Endocrinology;2024-02-15

5. Pathogenesis, assessment, and management of bone loss in axial spondyloarthritis;Seminars in Arthritis and Rheumatism;2024-02